| Key Financial Ratios of Eris Lifesciences (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
5.69 |
22.04 |
29.27 |
30.70 |
25.82 |
|
| Diluted EPS (Rs.) |
5.68 |
22.01 |
29.23 |
30.70 |
25.80 |
|
| Cash EPS (Rs.) |
19.03 |
29.56 |
34.02 |
34.48 |
28.59 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
184.65 |
185.55 |
163.39 |
141.11 |
116.03 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
184.65 |
185.55 |
163.39 |
141.11 |
116.03 |
|
| Dividend / Share(Rs.) |
7.35 |
0.00 |
7.35 |
6.01 |
5.50 |
|
| Revenue from Operations/Share (Rs.) |
124.65 |
109.29 |
97.85 |
89.44 |
81.66 |
|
| PBDIT/Share (Rs.) |
38.33 |
35.92 |
38.41 |
37.74 |
31.47 |
|
| PBIT/Share (Rs.) |
24.98 |
28.39 |
33.66 |
33.95 |
28.70 |
|
| PBT/Share (Rs.) |
8.81 |
24.17 |
32.13 |
33.73 |
28.64 |
|
| Net Profit/Share (Rs.) |
5.68 |
22.03 |
29.27 |
30.69 |
25.82 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
30.75 |
32.86 |
39.25 |
42.19 |
38.53 |
|
| PBIT Margin (%) |
20.04 |
25.98 |
34.39 |
37.96 |
35.14 |
|
| PBT Margin (%) |
7.07 |
22.11 |
32.83 |
37.71 |
35.07 |
|
| Net Profit Margin (%) |
4.55 |
20.15 |
29.90 |
34.31 |
31.61 |
|
| Return on Networth / Equity (%) |
3.07 |
11.87 |
17.91 |
21.75 |
22.25 |
|
| Return on Capital Employed (%) |
8.04 |
12.50 |
18.30 |
23.26 |
24.19 |
|
| Return on Assets (%) |
1.48 |
5.60 |
14.29 |
19.40 |
19.97 |
|
| Total Debt/Equity (X) |
0.88 |
1.00 |
0.14 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.32 |
0.37 |
0.54 |
0.62 |
63.18 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.63 |
0.83 |
1.95 |
3.49 |
2.93 |
|
| Quick Ratio (X) |
0.44 |
0.79 |
1.72 |
2.98 |
2.48 |
|
| Inventory Turnover Ratio (X) |
0.48 |
1.24 |
1.54 |
1.57 |
17.10 |
|
| Dividend Payout Ratio (NP) (%) |
129.29 |
0.00 |
25.10 |
19.57 |
21.30 |
|
| Dividend Payout Ratio (CP) (%) |
38.60 |
0.00 |
21.59 |
17.42 |
19.23 |
|
| Earnings Retention Ratio (%) |
-29.29 |
0.00 |
74.90 |
80.43 |
78.70 |
|
| Cash Earnings Retention Ratio (%) |
61.40 |
0.00 |
78.41 |
82.58 |
80.77 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
21,413.22 |
12,675.55 |
8,048.53 |
9,320.83 |
8,174.56 |
|
| EV/Net Operating Revenue (X) |
12.61 |
8.53 |
6.05 |
7.67 |
7.37 |
|
| EV/EBITDA (X) |
41.02 |
25.94 |
15.41 |
18.17 |
19.13 |
|
| MarketCap/Net Operating Revenue (X) |
11.36 |
7.70 |
5.85 |
7.70 |
7.40 |
|
| Retention Ratios (%) |
-29.29 |
0.00 |
74.89 |
80.42 |
78.69 |
|
| Price/BV (X) |
7.67 |
4.53 |
3.50 |
4.88 |
5.21 |
|
| Price/Net Operating Revenue |
11.36 |
7.70 |
5.85 |
7.70 |
7.40 |
|
| Earnings Yield |
0.00 |
0.03 |
0.05 |
0.04 |
0.04 |
|
Source : Dion Global Solutions Limited
